Work

Rilzabrutinib and Bruton tyrosine kinase inhibition for the treatment of persistent or chronic immune thrombocytopenia

Year: 2025

Type: article

Source: Expert Opinion on Pharmacotherapy

DOI: 10.1080/14656566.2025.2574850

Authors: Donald C. Moore, P. Christopher Parish, Justin R. Arnall, Joseph B. Elmes

Institutions: Levine Cancer Institute, Atrium Health Wake Forest Baptist, Wake Forest Baptist Comprehensive Cancer Center

Language: English

Topic: Platelet Disorders and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415109348

FWCI: 1.277

Cites: 31

Cited by: 2

Related to: